Aesthetic Medicine feature the new published study in Journal of Drugs in Dermatology, showing the efficacy of the Endocare CELLPRO range.
CELLPRO increases collagen and elastin and significantly transforms ageing skin with its unique growth factor complex; CAF BioAction and powerful Vitamin A.
The study researched the efficacy of our Endocare skincare range, which provides the ultimate skin rejuvenation combination, bringing together the latest innovations in stem cell activators and growth factors, with technologies Vitamin A and C. The study by Dr Hema Sundaram MD, entitled “The Mechanisms and Potential Impact of Stem Cell Activation in Skin Rejuvenation: An Evidence-Based Analysis” investigated the potential impact of stem cell activators on skin rejuvenation. She discovered that CAF BioAction, unique to the Endocare CELLPRO range, is clinically proven to generate new fibroblasts, whilst also stimulating existing ones. The result? More collagen and more elastin for results that will transform the look of your skin.
Find out more about the Endocare CELLPRO range and read the full study by Dr Hema Sundaram MD here: http://aestheticare.dev.sawblade.org.uk/endocare-cellpro/
You can read the full article in Aesthetics Medicine Magazine.